Featured Publications
Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis
Martin A, Bonfils KA, Davis BJ, Smith EA, Schuder K, Lysaker PH. Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis. Schizophrenia Research Cognition 2016, 6: 15-21. PMID: 28740820, PMCID: PMC5514308, DOI: 10.1016/j.scog.2016.09.001.Peer-Reviewed Original ResearchLifetime cannabisCannabis useLess impairmentGroup of patientsDose related responsePoor levelCannabis/Assessment of neurocognitionLifetime cannabis usePoor cognitionSevere impairmentCognitive deficitsCognitive functionLower cannabisModerate cannabisCannabisSchizophreniaImpairmentHigher cannabisNeurocognition
2024
Recent Advances in Prevention and Recovery in People with Schizophrenia and Related Disorders
Martin A, Bonfils K. Recent Advances in Prevention and Recovery in People with Schizophrenia and Related Disorders. Behavioral Sciences 2024, 14: 988. PMID: 39594288, PMCID: PMC11591413, DOI: 10.3390/bs14110988.Peer-Reviewed Original Research
2023
Cannabis Causes Positive, Negative, and Cognitive Symptoms and Produces Impairments in Electrophysiological Indices of Information Processing
Martin A, Ranganathan M, D’Souza D. Cannabis Causes Positive, Negative, and Cognitive Symptoms and Produces Impairments in Electrophysiological Indices of Information Processing. 2023, 156-166. DOI: 10.1017/9781108943246.017.Peer-Reviewed Original ResearchMental illnessMental health teamsHealth policy implicationsHigh-potency cannabisStages of neurodevelopmentPotential adverse effectsHealth teamsImpact of exposureCognitive symptomsCannabis dependenceAdverse effectsCannabisSynthetic cannabinoidsIllnessPsychosisCannabinoidsElectrophysiological indicesNew research findingsAssociationComplex associationSymptomsPutative modelNeurodevelopmentSchizophreniaImpairment
2022
The Relationship Between Cannabinoids and Neural Oscillations: How Cannabis Disrupts Sensation, Perception, and Cognition
Syed S, Martin A, Cortes-Briones J, Skosnik P. The Relationship Between Cannabinoids and Neural Oscillations: How Cannabis Disrupts Sensation, Perception, and Cognition. Clinical EEG And Neuroscience 2022, 54: 359-369. PMID: 36426543, DOI: 10.1177/15500594221138280.Peer-Reviewed Original ResearchConceptsNeural oscillationsNeural synchronyImportant clinical implicationsExcitatory balanceTheta frequency rangeClinical studiesClinical implicationsNeural circuitsCannabis useBrain functionOscillatory disruptionsNeural activityCannabinoidsSensationPotential relationshipCritical mechanismElectroencephalographyDisruptionSchizophrenia
2019
Metacognition and recovery in schizophrenia: From research to the development of metacognitive reflection and insight therapy
Lysaker P, Kukla M, Vohs J, Martin A, Buck K, Ohayon I. Metacognition and recovery in schizophrenia: From research to the development of metacognitive reflection and insight therapy. Journal Of Experimental Psychopathology 2019, 10: 2043808718814992. DOI: 10.1177/2043808718814992.Peer-Reviewed Original Research
2017
The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition
Helle S, Løberg EM, Gjestad R, Martin A, Lysaker PH. The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition. Psychiatry Research 2017, 250: 92-98. PMID: 28152399, DOI: 10.1016/j.psychres.2017.01.047.Peer-Reviewed Original ResearchConceptsSocial cognitionTheory of mindExecutive functionCannabis useBell-Lysaker Emotion Recognition TestEmotion Recognition TestExecutive Functioning ScaleBetter executive functionRegular cannabis useStructural equation modelingHinting testIllicit substancesNeurocognitive vulnerabilityRecognition testNeurocognitive performanceNeurocognitive deficitsCognitionEquation modelingFlexibility componentsAlcohol useFunctioning ScaleLifetime cannabisIndirect effectsPositive linkSchizophrenia